Table 1.

Active compounds encapsulated within bovine serum albumin (BSA) nanoparticles.

Active Compound	Preparation Method	Goal	Ref.
5-Fluorouracil	Coacervation	In vitro drug release profile	[8]
10-hydroxycamptothecin	W/O Emulsion	Characterization of nanoparticles and in vitro targeted delivery profile	[19]
Aspirin	Coacervation	Preparing formulations for intra-articular therapy	[20]
Cefamandole nafate (antibiotic)	W/O emulsion	Prevention of medical device-related infections	[21]
Doxorubicin	Desolvation	Tumor inhibition of murine ascites hepatoma	[22]
γ-Interferon	Coacervation	Targeting of γ-interferon into macrophages	[23]
Ganciclovir	Coacervstion	In vitro drug release profile of nanoparticles	[24]
Methotrexate	Coacervation	Study the biodistribution of nanoparticles	[25]
Oligonucleotides	Coacervation	Delivery of antisense oligonucleotides	[26]
Paclitaxel	Deslovation	Characterization and in vitro targeted delivery profile	[27]
Pilocarpine	Desolvation	The effect of bioadhesive polymer on the in vivo activity of nanoparticles	[28]
Sodium Ferulate	Desolvation	Liver targeting	[29]